Not applicableUnknownNCT04988100What this trial is testingImpact of Splenic Artery Ligation in LDLT for Patients With Portal HypertensionWho this might be right forLiving Donor Liver Transplantation Assiut University 30
Not applicableLooking for participantsNCT06718517What this trial is testingImpact of a TDM-guided ECPA Program for Optimizing Pharmacodynamic Target Attainment of Continuous Infusion Beta-lactam-based RegimenWho this might be right forLiver Transplant Infection IRCCS Azienda Ospedaliero-Universitaria di Bologna 65
Post-approval studies (Phase 4)Study completedNCT05152628What this trial is testingModigraf® (Tacrolimus Granules) to Evaluate the Pharmacokinetics and Long-term Safety and Efficacy in De Novo Pediatric Allograft Liver and Kidney Transplantation RecipientsWho this might be right forLiver TransplantationKidney Transplantation Astellas Pharma China, Inc. 55
Not applicableNot Yet RecruitingNCT06916325What this trial is testingOpen Label Trial of Deceased Donor Livers Transplanted After DHOPE With eXVIVO LIVER PerfusionWho this might be right forLiver Transplant SurgeryLiver Transplantation XVIVO Perfusion 215
Not applicableUnknownNCT02119585What this trial is testingAnalysis of Respiratory System Mechanics and Inflammatory Response During Orthotopic Liver Transplantation (SPPLIT Trial)Who this might be right forEnd Stage Liver Diseases University of Turin, Italy 30
Not applicableEnded earlyNCT00867243What this trial is testingPrediction of Hepatitis C Recurrence in Liver Transplant RecipientsWho this might be right forComplication of Transplanted LiverHepatitis C, Chronic Northwestern University 24
Large-scale testing (Phase 3)UnknownNCT03578055What this trial is testingBDD With UDCA Therapy After Laparoscopic CholecystectomyWho this might be right forCholecystitis, AcuteCholecystitis, Chronic Ewha Womans University Mokdong Hospital 172
Not applicableUnknownNCT05913583What this trial is testingCorrelation Between Pre-transplant ICI Exposure and Post-transplant Graft RejectionWho this might be right forGraft RejectionHepatocellular CarcinomaImmunotherapy+1 more Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University 160
Not applicableActive Not RecruitingNCT04390724What this trial is testingOptimizing Y90 Therapy for Radiation LobectomyWho this might be right forHCCResectionTransplant+2 more Northwestern University 104
Not applicableStudy completedNCT03402256What this trial is testingText Messaging to Reduce Alcohol Relapse in Liver Transplant PatientsWho this might be right forAlcoholic Liver Disease Yale University 15
Testing effectiveness (Phase 2)Study completedNCT00282256What this trial is testingA Modified-Release Tacrolimus Based Immunosuppression Regimen in Stable Pediatric Liver Transplant PatientsWho this might be right forLiver Transplantation Astellas Pharma Inc 19
Testing effectiveness (Phase 2)Study completedNCT02533180What this trial is testingEvaluation of Donor Specific Immune Senescence and Exhaustion as Biomarkers of Tolerance Post Liver TransplantationWho this might be right forLiver TransplantLiver Transplantation National Institute of Allergy and Infectious Diseases (NIAID) 100
Not applicableStudy completedNCT05431361What this trial is testingPRehab tO PreparE Living Liver Donors for Enhanced RecoveryWho this might be right forLiving Donor Liver Transplantation University Health Network, Toronto 30
Not applicableStudy completedNCT07572305What this trial is testingEffects of Virtual Reality After Liver TransplantationWho this might be right forLiver TransplantationPostoperative PainFatigue Malatya Turgut Ozal University 84
Not applicableWithdrawnNCT00834496What this trial is testingSwitching From One Type of Anti-rejection Drug (Tacrolimus or Cyclosporine) to Another (Sirolimus) Approximately 90-180 Days After Liver TransplantationWho this might be right forSide Effects of Calcineurin InhibitorsRenal ToxicityHepatic Fibrosis on Biopsy+2 more Thomas Jefferson University
Testing effectiveness (Phase 2)Looking for participantsNCT05424003What this trial is testingRandomized Double Blinded Placebo-Controlled w/Semaglutide to Prevent Weight Gain After Liver TransplantWho this might be right forNAFLD University of Virginia 50
Not applicableUnknownNCT01944527What this trial is testingUse of Direct-acting Antiviral to Treat HCV Recurrence After Liver Transplantation (ANRSCO23CUPILT) InfectionWho this might be right forHCV RecurrenceLiver TransplantationDirect-acting Antiviral Agents ANRS, Emerging Infectious Diseases 699
Not applicableEnded earlyNCT05184283What this trial is testingUtilization of MAsS in Patients Undergoing LT for HCCWho this might be right forNAFLDHepatocellular CarcinomaLiver Diseases+3 more Columbia University 11
Not applicableStudy completedNCT04853641What this trial is testingImpact of Age and BMI on Liver Transplant OutcomesWho this might be right forLiver Transplant; ComplicationsPerioperative/Postoperative Complications University of Pittsburgh 700
Large-scale testing (Phase 3)Study completedNCT00469131What this trial is testingEffects of Immunosuppression on HCV Recurrence After Living Donor Liver Transplantation - Comparative Study Between Tacrolimus + MMF and Tacrolimus + SteroidWho this might be right forHepatitis CLiver Cirrhosis Translational Research Center for Medical Innovation, Kobe, Hyogo, Japan 79